Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Rabbit Polyclonal (IgG) to Human DRD1 / Dopamine Receptor D1
ICC, Western blot, ELISA
Human DRD1 / Dopamine Receptor D1
Human (tested or 100% immunogen sequence identity)
Specificity and Use
DRD1 / Dopamine Receptor D1 antibody was raised against d1 (Ac-9-21) covalently attached onto a carrier protein.
Recognizes D1 Dopamine Receptor (9-21) and the reactivity of D1 Dopamine Receptor is 90%. Does not react to D2 Dopamine Receptor (272-282), D2 Dopamine Receptor, D3 Dopamine Receptor (2-10), D3 Dopamine Receptor, D4 Dopamine Receptor (176-185), D4 Dopamine Receptor, D5 Dopamine Receptor (23-35) and D5 Dopamine Receptor. Highly specific for this peptide sequence and are suitable for the Western Blot detection of the D1 dopamine receptor.
Suitable for use in ELISA, Western Blot and Immunocytochemistry.
DRD1, a Dopamine Receptor, mediates the effect of the neurotransmitter dopamine, an intermediate in the biosynthesis of noradrenaline and adrenaline. It is involved in the control of motor activity and cognitive memory. Downregulation of DRD1 leads to severe impairments in working memory and to locomotor hyperactivity, which are observed in diseases such as schizophrenia, Parkinson's disease, affective disorders, and attention deficit hyperactivity disorder.